Approval · Notice of Compliance 17461 · 2015
TRULICITY: Notice of Compliance 17461
Issued November 10, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17461
- Date
- November 10, 2015
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- DULAGLUTIDE 0.75 MG per 0.5ML
- DULAGLUTIDE 1.5 MG per 0.5ML